Target Name: GPHN
NCBI ID: G10243
Review Report on GPHN Target / Biomarker Content of Review Report on GPHN Target / Biomarker
GPHN
Other Name(s): Gephyrin, transcript variant 2 | HKPX1 | MPT Mo-transferase | GEPH_HUMAN | GPHN variant 1 | Geph2 | GEPH | GPH | Domain E | MOCODC | gephyrin | Gephyrin isoform 2 | GephP1 | KIAA1385 | Gephyrin isoform 1 | GPHN variant 2 | Molybdopterin molybdenumtransferase | Gephyrin, transcript variant 1 | GPHRYN | MPT adenylyltransferase | Gephyrin | Domain G | Molybdopterin adenylyltransferase

GPHN: A unique protein involved in neurotransmission

GPHN, or Gephyrin transcript variant 2, is a protein that is expressed in the brain and nervous system. It is a member of the Gephyrin gene family, which is known for the production of receptor proteins that play a critical role in the neurotransmitter signaling system. GPHN is a unique protein, as it is only expressed in the brain and nervous system, and it is not found in any other tissues or cells in the body.

The GPHN protein is known for its role in the neurotransmitter signaling system, specifically in the regulation of neurotransmitter release. It is a key regulator of the neurotransmitter release, and is involved in the production and release of a variety of neurotransmitters, including GABA, serotonin, and dopamine. GPHN is also involved in the regulation of neurotransmitter uptake and storage, as well as the modulation of neurotransmitter release by other molecules.

GPHN is a transmembrane protein, which means that it spans the cell membrane and is located in the brain and nervous system. It is characterized by a long extracellular domain that is involved in its interactions with other molecules, as well as a short intracellular domain that is involved in its localization and stability. The intracellular domain of GPHN contains a unique feature, known as a N-terminal transmembrane domain, which is involved in the regulation of GPHN's stability and localization.

GPHN is a unique protein that is expressed in only the brain and nervous system. It is not found in any other tissues or cells in the body, and it is not known to have any function outside of these cells. Despite its unique expression, GPHN is of great interest to researchers because of its role in the neurotransmitter signaling system. The study of GPHN and its function in the brain and nervous system may lead to new insights into the mechanisms of neurotransmission and the development of new treatments for a variety of neurological and psychiatric disorders.

In conclusion, GPHN is a protein that is expressed in the brain and nervous system that is involved in the regulation of neurotransmitter release. It is a unique protein that is not found in any other tissues or cells in the body, and its role in the neurotransmission system is of great interest to researchers. Further studies of GPHN and its function in the brain and nervous system may lead to new insights into the mechanisms of neurotransmission and the development of new treatments for a variety of neurological and psychiatric disorders.

Protein Name: Gephyrin

Functions: Microtubule-associated protein involved in membrane protein-cytoskeleton interactions. It is thought to anchor the inhibitory glycine receptor (GLYR) to subsynaptic microtubules (By similarity). Acts as a major instructive molecule at inhibitory synapses, where it also clusters GABA type A receptors (PubMed:25025157, PubMed:26613940)

The "GPHN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GPHN comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

GPI | GPI transamidase complex | GPI-GlcNAc transferase complex | GPIHBP1 | GPKOW | GPLD1 | GPM6A | GPM6B | GPN1 | GPN2 | GPN3 | GPNMB | GPR101 | GPR107 | GPR108 | GPR119 | GPR12 | GPR132 | GPR135 | GPR137 | GPR137B | GPR137C | GPR139 | GPR141 | GPR142 | GPR143 | GPR146 | GPR148 | GPR149 | GPR15 | GPR150 | GPR151 | GPR152 | GPR153 | GPR155 | GPR156 | GPR157 | GPR158 | GPR158-AS1 | GPR15LG | GPR160 | GPR161 | GPR162 | GPR17 | GPR171 | GPR173 | GPR174 | GPR176 | GPR179 | GPR18 | GPR180 | GPR182 | GPR183 | GPR19 | GPR199P | GPR20 | GPR21 | GPR22 | GPR25 | GPR26 | GPR27 | GPR3 | GPR31 | GPR32 | GPR33 | GPR34 | GPR35 | GPR37 | GPR37L1 | GPR39 | GPR4 | GPR42 | GPR45 | GPR50 | GPR52 | GPR55 | GPR6 | GPR61 | GPR62 | GPR63 | GPR65 | GPR68 | GPR75 | GPR75-ASB3 | GPR78 | GPR79 | GPR82 | GPR83 | GPR84 | GPR84-AS1 | GPR85 | GPR87 | GPR88 | GPR89A | GPR89B | GPRACR | GPRASP1 | GPRASP2 | GPRASP3 | GPRC5A